Rogers Corporation (ROG) capitalization

Current snapshot

Market Cap
$1.92B
17.8M shares × $107.33 · as of last filing 2026-03-31
Net Worth
$1.19B
Stockholders' equity · 2026-03-31
Enterprise Value
$1.75B
Market cap + debt − cash
Net Debt
-$166.0M
Debt $29.8M − Cash $195.8M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $1.67B
FY'24 2024-12-31 $1.89B
FY'23 2023-12-31 $2.47B
FY'22 2022-12-31 $2.27B
FY'21 2021-12-31 $5.16B
FY'20 2020-12-31 $2.90B
FY'19 2019-12-31 $2.33B
FY'18 2018-12-31 $1.85B
FY'17 2017-12-31 $3.00B
FY'16 2016-12-31 $1.40B
FY'15 2015-12-31 $963.3M
FY'14 2014-12-31 $1.52B
FY'13 2013-12-31 $1.09B
FY'12 2012-12-31 $843.8M
FY'11 2011-12-31 $617.0M
FY'11 2010-12-31 $612.2M
FY'11 2009-12-31 $475.6M

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $1.92B
Q4'25 2025-12-31 $1.63B
Q3'25 2025-09-30 $1.46B
Q2'25 2025-06-30 $1.26B
Q1'25 2025-03-31 $1.25B
Q4'24 2024-12-31 $1.88B
Q3'24 2024-09-30 $2.10B
Q2'24 2024-06-30 $2.24B
Q1'24 2024-03-31 $2.22B
Q4'23 2023-12-31 $2.46B
Q3'23 2023-09-30 $2.46B
Q2'23 2023-06-30 $3.03B
Q1'23 2023-03-31 $3.04B
Q4'22 2022-12-31 $2.22B
Q3'22 2022-09-30 $4.60B
Q2'22 2022-06-30 $4.98B
Q1'22 2022-03-31 $5.16B
Q4'21 2021-12-31 $5.11B
Q3'21 2021-09-30 $3.52B
Q2'21 2021-06-30 $3.78B
Q1'21 2021-03-31 $3.53B
Q4'20 2020-12-31 $2.90B
Q3'20 2020-09-30 $1.83B
Q2'20 2020-06-30 $2.33B
Q1'20 2020-03-31 $1.76B
Q4'19 2019-12-31 $2.32B
Q3'19 2019-09-30 $2.56B
Q2'19 2019-06-30 $3.23B
Q1'19 2019-03-31 $2.97B
Q4'18 2018-12-31 $1.82B
Q3'18 2018-09-30 $2.75B
Q2'18 2018-06-30 $2.08B
Q1'18 2018-03-31 $2.22B
Q4'17 2017-12-31 $2.96B
Q3'17 2017-09-30 $2.48B
Q2'17 2017-06-30 $2.01B
Q1'17 2017-03-31 $1.58B
Q4'16 2016-12-31 $1.38B
Q3'16 2016-09-30 $1.11B
Q2'16 2016-06-30 $1.12B
Q1'16 2016-03-31 $1.09B
Q4'15 2015-12-31 $926.0M
Q3'15 2015-09-30 $991.8M
Q2'15 2015-06-30 $1.26B
Q1'15 2015-03-31 $1.56B
Q4'14 2014-12-31 $1.50B
Q3'14 2014-09-30 $1.03B
Q2'14 2014-06-30 $1.24B
Q1'14 2014-03-31 $1.16B
Q4'13 2013-12-31 $1.10B
Q3'13 2013-09-30 $1.06B
Q2'13 2013-06-30 $832.8M
Q1'13 2013-03-31 $841.6M
Q4'12 2012-12-31 $839.5M
Q3'12 2012-09-30 $721.1M
Q2'12 2012-06-30 $668.0M
Q1'12 2012-03-31 $629.0M
Q4'11 2011-12-31 $597.9M
Q3'11 2011-09-30 $662.6M
Q2'11 2011-06-30 $770.5M
Q1'12 2011-03-31 $744.8M
Q4'11 2010-12-31 $605.9M
Q3'11 2010-09-30 $503.9M
Q2'11 2010-06-30 $443.9M

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (ROG CIK 0000084748), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

ACRV

Acrivon Therapeutics, Inc.

FINW

FINWISE BANCORP

PACB

Pacific Biosciences of California, Inc.